<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6868923/results/search/disease/results.xml">
  <result pre="of flavonoids present in aerial parts of Marcetia taxifolia against" exact="Hepatitis" post="B virus, Poliovirus, and Herpes Simplex Virus in vitro"/>
  <result pre="to the presence of active metabolites. Nevertheless, there is a" exact="limited" post="quantity of studies related to the antiviral activity of"/>
  <result pre="from the aerial parts of Marcetia taxifolia was evaluated against" exact="Hepatitis" post="B virus (HBV), Herpes Simplex Virus type 1 (HSV-1),"/>
  <result pre="was evaluated against Hepatitis B virus (HBV), Herpes Simplex Virus" exact="type 1" post="(HSV-1), and Poliovirus type 1 (PV-1). The cytopathic effect"/>
  <result pre="virus (HBV), Herpes Simplex Virus type 1 (HSV-1), and Poliovirus" exact="type 1" post="(PV-1). The cytopathic effect and viral quantification by qPCR"/>
  <result pre="(HSV-1), and Poliovirus type 1 (PV-1). The cytopathic effect and" exact="viral" post="quantification by qPCR were determined as indicative of antiviral"/>
  <result pre="develop new antiviral compounds. antiviral flavonoids Marcetia taxifolia HBV HSV" exact="polio" post="Introduction Emergence, resistance and spreading of viral strains promote"/>
  <result pre="taxifolia HBV HSV polio Introduction Emergence, resistance and spreading of" exact="viral" post="strains promote research for new antiviral drugs. In fact,"/>
  <result pre="properties. These inhibitory effects could be related to blocking main" exact="viral" post="enzymes directly or in some cases, to be modulating"/>
  <result pre="antiviral and drugs that block a host cellular process avoiding" exact="viral" post="replication (Ortega et al., 2013[32]). Marcetia is a Neotropical"/>
  <result pre="aerial parts of Marcetia taxifolia were evaluated against three different" exact="viral" post="families of public health concern: Hepatitis B virus (HBV),"/>
  <result pre="evaluated against three different viral families of public health concern:" exact="Hepatitis" post="B virus (HBV), Herpes simplex virus (HSV) and Poliovirus"/>
  <result pre="around 240 million people worldwide and is related to hepatic" exact="cirrhosis" post="and hepatocellular carcinoma (WHO, 2019[46]). HSV may produce oral"/>
  <result pre="million people worldwide and is related to hepatic cirrhosis and" exact="hepatocellular carcinoma" post="(WHO, 2019[46]). HSV may produce oral or genital lesion"/>
  <result pre="people worldwide and is related to hepatic cirrhosis and hepatocellular" exact="carcinoma" post="(WHO, 2019[46]). HSV may produce oral or genital lesion"/>
  <result pre="activity of compounds isolated from Marcetia taxifolia against these different" exact="viral" post="families. Material and Methods Cell culture, viruses, and compounds"/>
  <result pre="kindly donated by Dr. Isabelle Chemin (Team leader Hepatocarcinogenesis and" exact="viral" post="infections) from INSERM, France. These cells were grown in"/>
  <result pre="under 5 % CO2 in a CO2 incubator. Herpes simplex" exact="type 1" post="F strain (HSV-1), poliovirus type 1 Sabin strain (PV-1)"/>
  <result pre="CO2 incubator. Herpes simplex type 1 F strain (HSV-1), poliovirus" exact="type 1" post="Sabin strain (PV-1) of viral repository stocks from &quot;Cátedra"/>
  <result pre="F strain (HSV-1), poliovirus type 1 Sabin strain (PV-1) of" exact="viral" post="repository stocks from &quot;Cátedra Virología, Facultad de Farmacia y"/>
  <result pre="and incubated by 72 h. The supernatant was collected and" exact="viral" post="DNA extracted using High Pure Viral Nucleic Acid Kit"/>
  <result pre="supernatant was collected and viral DNA extracted using High Pure" exact="Viral" post="Nucleic Acid Kit (Roche Life Science, Germany). The development"/>
  <result pre="at 61 °C and 30 sec. at 72 °C. The" exact="viral" post="inhibition relative to control (%) was calculated. Statistical analyses"/>
  <result pre="at least three independent experiments were performed. Herpes virus and" exact="polio" post="antiviral assay To determine the antiviral activity against Herpes"/>
  <result pre="10 % formalin and stained with 0.4 % crystal violet." exact="Viral infection," post="cellular morphology, and cytotoxic controls in each assay were"/>
  <result pre="building and refinement Homology modeling A homology model of the" exact="Hepatitis" post="B virus Reverse Transcriptase (HBV-RT) was generated by using"/>
  <result pre="1997[13]). In this model, hydrogen atoms were added, and the" exact="partial" post="charges were assigned for energy refinement. After that, the"/>
  <result pre="assayed. Table 1(Tab. 1) summarizes the results for cytotoxicity and" exact="viral" post="inhibition for the evaluated compounds. As indicated in this"/>
  <result pre="atoms (Table 2(Tab. 2)). The conformational differences related to the" exact="secondary" post="structure between HIV-RT and HBV-RT were determined. The main"/>
  <result pre="binding energy of -5.33 kcal/mol. However, the glycosylated flavonoids showed" exact="lower" post="binding energy than methoxyflavones. The best ranked binding energy"/>
  <result pre="(Figure 5(Fig. 5) and Table 3(Tab. 3)). The methoxyflavones showed" exact="lower" post="binding energies compared to the glycosylated compounds. Additionally, these"/>
  <result pre="these compounds produce more hydrogen bonds, which suggest a more" exact="stable" post="interaction with the HBV-RT. These docking results are in"/>
  <result pre="To determine the antiviral spectrum of these flavonoids, two additionally" exact="viral" post="species were selected as models. PV-1 (a single strain"/>
  <result pre="the glycosylated flavonoids did not have an inhibitory effect against" exact="Polio" post="nor Herpes. These observations are in concordance with previous"/>
  <result pre="et al., 1986[6]). The methoxyflavones displayed a potent effect against" exact="Polio" post="and these results are in agreement with previous reports"/>
  <result pre="showed that the methoxyflavones are active against Polio, Herpes, and" exact="Hepatitis" post="B. Additionally, as previously mentioned the methoxyflavones can inhibit"/>
  <result pre="of methoxyflavones may suggest two possible inhibitory mechanisms: a) inhibiting" exact="viral" post="polymerases by acting as non-selective inhibitors, or b) modulating"/>
  <result pre="inhibitors, or b) modulating a cellular process related to the" exact="viral" post="replication cycle. Indeed, methoxyflavones have been described as inhibitors"/>
  <result pre="mitochondrial-associated cell death via reactive oxygen species signaling in human" exact="colon carcinoma" post="cellsPLoS One2016114e015452527116119 6CastrilloJLVandenBergheDCarrascoL3-Methylquercetin is a potent and selective inhibitor"/>
  <result pre="cell death via reactive oxygen species signaling in human colon" exact="carcinoma" post="cellsPLoS One2016114e015452527116119 6CastrilloJLVandenBergheDCarrascoL3-Methylquercetin is a potent and selective inhibitor"/>
  <result pre="and selective inhibitor of poliovirus RNA synthesisVirology19861522192273012868 7ChengZSunGGuoWHuangYSunWZhaoFet al.Inhibition of" exact="hepatitis" post="B virus replication by quercetin in human hepatoma cell"/>
  <result pre="quercetin in human hepatoma cell linesVirol Sin20153026126826268473 8DagaPRDuanJDoerksenRJComputational model of" exact="hepatitis" post="B virus DNA polymerase: Molecular dynamics and docking to"/>
  <result pre="protein modelingElectrophoresis199718271427239504803 14HuangHZhouWZhuHZhouPShiXBaicalin benefits the anti-HBV therapy via inhibiting HBV" exact="viral" post="RNAsToxicol Appl Pharmacol2017;15323364328322895 15IzaguirreJACatarelloDPWozniakJMSkeelRDLangevin stabilization of molecular dynamicsJ Chem"/>
  <result pre="vivo anticancer activity through the suppression of NF-?B/Akt signaling in" exact="prostate cancer" post="cellsInt J Mol Med20143331732424285354 18KimSThiessenPABoltonEEChenJFuGGindulyteAet al.PubChem Substance and Compound"/>
  <result pre="anticancer activity through the suppression of NF-?B/Akt signaling in prostate" exact="cancer" post="cellsInt J Mol Med20143331732424285354 18KimSThiessenPABoltonEEChenJFuGGindulyteAet al.PubChem Substance and Compound"/>
  <result pre="24MaWFengSYaoXYuanZLiuLXieYNobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression" exact="cancer" post="cellsSci Rep201551878926689156 25MasellaMThe multiple time step r-RESPA procedure and"/>
  <result pre="anti-HIV-1 activity in vitroAIDS Res Ther20171415729025433 35ParvezMKArbabAHAl-DosariMSAl-RehailyAJAntiviral natural products against" exact="chronic hepatitis" post="B: Recent developmentsCurr Pharm Des20162228629326561057 36PedrettiAVillaLVistoliGVEGA - An open"/>
  <result pre="activity in vitroAIDS Res Ther20171415729025433 35ParvezMKArbabAHAl-DosariMSAl-RehailyAJAntiviral natural products against chronic" exact="hepatitis" post="B: Recent developmentsCurr Pharm Des20162228629326561057 36PedrettiAVillaLVistoliGVEGA - An open"/>
  <result pre="al.Scalable molecular dynamics with NAMDJ Comput Chem2005261781802 38QuinteroAFabbroRMailloMBarriosMMilanoMBFernndezAet al.Inhibition of" exact="hepatitis" post="B virus and human immunodeficiency virus (HIV-1) replication by"/>
  <result pre="Comput Chem2005261781802 38QuinteroAFabbroRMailloMBarriosMMilanoMBFernndezAet al.Inhibition of hepatitis B virus and human" exact="immunodeficiency" post="virus (HIV-1) replication by Warscewiczia coccinea (Vahl) Kl. (Rubiaceae)"/>
  <result pre="(Vahl) Kl. (Rubiaceae) ethanol extractNat Prod Res2011251565156921827337 39SellsMAZelentAZShvartsmanMAcsGReplicative intermediates of" exact="hepatitis" post="B virus in HepG2 cells that produce infectious virionsJ"/>
  <result pre="intermediates of hepatitis B virus in HepG2 cells that produce" exact="infectious" post="virionsJ Virol198862283628442839705 40SharmaMAndersonSASchoopRHudsonJBInduction of multiple pro-inflammatory cytokines by respiratory"/>
  <result pre="produce infectious virionsJ Virol198862283628442839705 40SharmaMAndersonSASchoopRHudsonJBInduction of multiple pro-inflammatory cytokines by" exact="respiratory" post="viruses and reversal by standardized Echinacea, a potent antiviral"/>
  <result pre="standardized Echinacea, a potent antiviral herbal extractAntiviral Res20098316517019409931 41ShiMDLiaoYCShihYWTsaiLYNobiletin attenuates" exact="metastasis" post="via both ERK and PI3K/Akt pathways in HGF-treated liver"/>
  <result pre="attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated" exact="liver cancer" post="HepG2 cellsPhytomedicine20132074375223537747 42ToukmajiASaguiCBoardJDardenTEfficient particle-mesh Ewald based approach to fixed"/>
  <result pre="metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver" exact="cancer" post="HepG2 cellsPhytomedicine20132074375223537747 42ToukmajiASaguiCBoardJDardenTEfficient particle-mesh Ewald based approach to fixed"/>
  <result pre="all-atom additive biological force fieldsJ Comput Chem20103167190 45WhitleyRBainesJClinical management of" exact="herpes" post="simplex virus infections: past, present, and futureF1000Res20187F1000 Faculty RevF1000"/>
  <result pre="Hematol Oncol201145222185222 49ZhangQGWeiFLiuQChenLJLiuYYLuoFet al.The flavonoid from Polygonum perfoliatum L. inhibits" exact="herpes" post="simplex virus 1 infectionActaVirol201458368373 Table 1 Cytotoxic concentration and"/>
  <result pre="MyrGG Figure 3 Sequence alignment of HBV-RT and HIV-1-RT polymerases." exact="Secondary" post="structure prediction of HBV-RT. Predicted amino acid sequences of"/>
 </snippets>
</snippetsTree>
